Clinical Trial Update: Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating piritrexim in advanced urinary tract cancers has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Cancer of the Renal Pelvis and Ureter
• Urethral Cancer

Drugs mentioned

• Piritrexim (piritrexim)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED